Citations (123)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mary Mazzotta Heckler & Rebecca B Riggins. (2015) ERRβ splice variants differentially regulate cell cycle progression. Cell Cycle 14:1, pages 31-45.
Read now
Read now
Lei Duan, Ricardo E Perez, Michael Hansen, Steven Gitelis & Carl G Maki. (2014) Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Cancer Biology & Therapy 15:12, pages 1600-1612.
Read now
Read now
Tushar Deb, Robert Barndt, Annie Zuo, Surojeet Sengupta, Christine Coticchia & Michael Johnson. (2014) PTEN-mediated ERK1/2 inhibition and paradoxical cellular proliferation following Pnck overexpression. Cell Cycle 13:6, pages 961-973.
Read now
Read now
Jung-Sik Kim, Xuehua Xu, Huifang Li, David Solomon, William S. Lane, Tian Jin & Todd Waldman. (2011) Mechanistic Analysis of a DNA Damage-Induced, PTEN-Dependent Size Checkpoint in Human Cells. Molecular and Cellular Biology 31:13, pages 2756-2771.
Read now
Read now
Vladimir L. Gabai, Julia A. Yaglom, Todd Waldman & Michael Y. Sherman. (2009) Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells. Molecular and Cellular Biology 29:2, pages 559-569.
Read now
Read now
Daphne Haas-Kogan & David Stokoe. (2008) PTEN in brain tumors. Expert Review of Neurotherapeutics 8:4, pages 599-610.
Read now
Read now
Articles from other publishers (117)
Jun Zhang, Jacob Croft & Alexander Le. (2023) Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations. Journal of Personalized Medicine 13:4, pages 673.
Crossref
Crossref
Sophie Mueller, Isabel Grote, Stephan Bartels, Leonie Kandt, Henriette Christgen, Ulrich Lehmann, Oleg Gluz, Monika Graeser, Ron Kates, Nadia Harbeck, Hans Kreipe & Matthias Christgen. (2023) p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance. Modern Pathology 36:4, pages 100100.
Crossref
Crossref
Alessandro Mussa, Chiara Leoni, Matteo Iacoviello, Diana Carli, Carlotta Ranieri, Antonino Pantaleo, Paola Sabrina Buonuomo, Rosanna Bagnulo, Giovanni Battista Ferrero, Andrea Bartuli, Daniela Melis, Silvia Maitz, Daria Carmela Loconte, Antonella Turchiano, Marilidia Piglionica, Annunziata De Luisi, Francesco Claudio Susca, Nenad Bukvic, Cinzia Forleo, Angelo Selicorni, Giuseppe Zampino, Roberta Onesimo, Gerarda Cappuccio, Livia Garavelli, Chiara Novelli, Luigi Memo, Carla Morando, Matteo Della Monica, Maria Accadia, Martina Capurso, Carmelo Piscopo, Anna Cereda, Marilena Carmela Di Giacomo, Veronica Saletti, Alessandro Mauro Spinelli, Patrizia Lastella, Romano Tenconi, Veronika Dvorakova, Alan D Irvine & Nicoletta Resta. (2023) Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants. Journal of Medical Genetics 60:2, pages 163-173.
Crossref
Crossref
Maxim Karagyaur, Alexandra Primak, Anastasia Efimenko, Mariya Skryabina & Vsevolod Tkachuk. (2022) The Power of Gene Technologies: 1001 Ways to Create a Cell Model. Cells 11:20, pages 3235.
Crossref
Crossref
Sakthivel Muniyan, Ramesh Pothuraju, Parthasarathy Seshacharyulu & Surinder K. Batra. (2022) Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype. Cancer Letters 536, pages 215664.
Crossref
Crossref
Andrea C Florian, Chase M Woodley, Jing Wang, Brian C Grieb, Macey J Slota, Kiana Guerrazzi, Chih-Yuan Hsu, Brittany K Matlock, David K Flaherty, Shelly L Lorey, Stephen W Fesik, Gregory C Howard, Qi Liu, April M Weissmiller & William P Tansey. (2022) Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. NAR Cancer 4:1.
Crossref
Crossref
Forough Alemi, Aydin Raei sadigh, Faezeh Malakoti, Yusuf Elhaei, Seyed Hamed Ghaffari, Masomeh Maleki, Zatollah Asemi, Bahman Yousefi, Niloufar Targhazeh & Maryam Majidinia. (2021) Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk. Journal of Cellular Physiology 237:1, pages 313-328.
Crossref
Crossref
Neha Singh, Varune R. Ramnarine, Jin H. Song, Ritu Pandey, Sathish K. R. Padi, Mannan Nouri, Virginie Olive, Maxim Kobelev, Koichi Okumura, David McCarthy, Michelle M. Hanna, Piali Mukherjee, Belinda Sun, Benjamin R. Lee, J. Brandon Parker, Debabrata Chakravarti, Noel A. Warfel, Muhan Zhou, Jeremiah J. Bearss, Ewan A. Gibb, Mohammed Alshalalfa, R. Jefferey Karnes, Eric J. Small, Rahul Aggarwal, Felix Feng, Yuzhuo Wang, Ralph Buttyan, Amina Zoubeidi, Mark Rubin, Martin Gleave, Frank J. Slack, Elai Davicioni, Himisha Beltran, Colin Collins & Andrew S. Kraft. (2021) The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nature Communications 12:1.
Crossref
Crossref
Mónica T. Fernandes, Victor Yassuda, José Bragança, Wolfgang Link, Bibiana I. Ferreira & Ana Luísa De Sousa-Coelho. (2021) Tribbles Gene Expression Profiles in Colorectal Cancer. Gastrointestinal Disorders 3:4, pages 218-236.
Crossref
Crossref
Tao Hong, Xiao Xiao, Jian Ren, Bing Cui, Yuru Zong, Jian Zou, Zqi Kou, Nan Jiang, Guolu Meng, Gao Zeng, Yongzhi Shan, Hao Wu, Zan Chen, Jiantao Liang, Xinru Xiao, Jie Tang, Yukui Wei, Ming Ye, Liyong Sun, Guilin Li, Peng Hu, Rutai Hui, Hongqi Zhang & Yibo Wang. (2021)
Somatic
MAP3K3
and
PIK3CA
mutations in sporadic cerebral and spinal cord cavernous malformations
. Brain 144:9, pages 2648-2658.
Crossref
Crossref
Bart Vanhaesebroeck, Matthew W. D. Perry, Jennifer R. Brown, Fabrice André & Klaus Okkenhaug. (2021) PI3K inhibitors are finally coming of age. Nature Reviews Drug Discovery 20:10, pages 741-769.
Crossref
Crossref
Jin Shin, Se-Hee Kim & Jin Yoon. (2021) PTEN downregulation induces apoptosis and cell cycle arrest in uterine cervical cancer cells. Experimental and Therapeutic Medicine 22:4.
Crossref
Crossref
Yan Qin Tan, Xi Zhang, Shuwei Zhang, Tao Zhu, Manoj Garg, Peter E. Lobie & Vijay Pandey. (2021) Mitochondria: The metabolic switch of cellular oncogenic transformation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188534.
Crossref
Crossref
Zahra Hasanpour Segherlou, Masoud Nouri‐Vaskeh, Sama Noroozi Guilandehi, Amir Baghbanzadeh, Ramin Zand, Behzad Baradaran & Mohammad Zarei. (2021) GDF‐15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme. Journal of Cellular Physiology 236:8, pages 5564-5581.
Crossref
Crossref
Rossana Aprigliano, Merdane Ezgi Aksu, Stefano Bradamante, Boris Mihaljevic, Wei Wang, Kristin Rian, Nicola P. Montaldo, Kayla Mae Grooms, Sarah L. Fordyce Martin, Diana L. Bordin, Matthias Bosshard, Yunhui Peng, Emil Alexov, Cindy Skinner, Nina-Beate Liabakk, Gareth J. Sullivan, Magnar Bjørås, Charles E. Schwartz & Barbara van Loon. (2021) Increased p53 signaling impairs neural differentiation in HUWE1-promoted intellectual disabilities. Cell Reports Medicine 2:4, pages 100240.
Crossref
Crossref
Maya Maor-Nof, Zohar Shipony, Rodrigo Lopez-Gonzalez, Lisa Nakayama, Yong-Jie Zhang, Julien Couthouis, Jacob A. Blum, Patricia A. Castruita, Gabriel R. Linares, Kai Ruan, Gokul Ramaswami, David J. Simon, Aviv Nof, Manuel Santana, Kyuho Han, Nasa Sinnott-Armstrong, Michael C. Bassik, Daniel H. Geschwind, Marc Tessier-Lavigne, Laura D. Attardi, Thomas E. Lloyd, Justin K. Ichida, Fen-Biao Gao, William J. Greenleaf, Jennifer S. Yokoyama, Leonard Petrucelli & Aaron D. Gitler. (2021) p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell 184:3, pages 689-708.e20.
Crossref
Crossref
Kumar Nikhil, Mohini Kamra, Asif Raza & Kavita Shah. (2021) Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo. Cancer Letters 498, pages 1-18.
Crossref
Crossref
Isabel de Pedro, Jesús Galán-Vidal, Ana Freije, Ernesto de Diego & Alberto Gandarillas. (2020) p21CIP1 controls the squamous differentiation response to replication stress. Oncogene 40:1, pages 152-162.
Crossref
Crossref
Bojana RisticSathish SivaprakasamMonisha NarayananVadivel Ganapathy. (2020) Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2. Biochemical Journal 477:8, pages 1499-1513.
Crossref
Crossref
Audra F Bryan, Jing Wang, Gregory C Howard, Alissa D Guarnaccia, Chase M Woodley, Erin R Aho, Eric J Rellinger, Brittany K Matlock, David K Flaherty, Shelly L Lorey, Dai H Chung, Stephen W Fesik, Qi Liu, April M Weissmiller & William P Tansey. (2020) WDR5 is a conserved regulator of protein synthesis gene expression. Nucleic Acids Research 48:6, pages 2924-2941.
Crossref
Crossref
Ana Marin Navarro, Robin Johan Pronk, Astrid Tjitske van der Geest, Ganna Oliynyk, Ann Nordgren, Marie Arsenian-Henriksson, Anna Falk & Margareta Wilhelm. (2020) p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death & Disease 11:1.
Crossref
Crossref
Ralitsa R. Madsen & Bart Vanhaesebroeck. (2020) Cracking the context-specific PI3K signaling code. Science Signaling 13:613.
Crossref
Crossref
Jinfang Zhang, Yu-Ru Lee, Fabin Dang, Wenjian Gan, Archita Venugopal Menon, Jesse M. Katon, Chih-Hung Hsu, John M. Asara, Priyanka Tibarewal, Nicholas R. Leslie, Yang Shi, Pier Paolo Pandolfi & Wenyi Wei. (2019) PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage. Cancer Discovery 9:9, pages 1306-1323.
Crossref
Crossref
Bart Vanhaesebroeck, Benoit Bilanges, Ralitsa Madsen, Katie Dale, Evelyn Lau & Elina Vladimirou. (2019) Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability. Biomolecules 9:8, pages 331.
Crossref
Crossref
Sofia Frisk, Fulya Taylan, Izabela Blaszczyk, Inger Nennesmo, Göran Annerén, Bettina Herm, Eva‐Lena Stattin, Vasilios Zachariadis, Anna Lindstrand, Bianca Tesi, Tobias Laurell & Ann Nordgren. (2019)
Early activating somatic
PIK3CA
mutations promote ectopic muscle development and upper limb overgrowth
. Clinical Genetics 96:2, pages 118-125.
Crossref
Crossref
Nicole Steinbach, Dan Hasson, Deepti Mathur, Elias E Stratikopoulos, Ravi Sachidanandam, Emily Bernstein & Ramon E Parsons. (2019) PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription. Nucleic Acids Research 47:11, pages 5573-5586.
Crossref
Crossref
Ralitsa R. Madsen, Rachel G. KnoxWayne PearceSaioa LopezBetania Mahler-Araujo, Nicholas McGranahanBart Vanhaesebroeck & Robert K. Semple. (2019)
Oncogenic
PIK3CA
promotes cellular stemness in an allele dose-dependent manner
. Proceedings of the National Academy of Sciences 116:17, pages 8380-8389.
Crossref
Crossref
Erin R. Aho, Jing Wang, Rocco D. Gogliotti, Gregory C. Howard, Jason Phan, Pankaj Acharya, Jonathan D. Macdonald, Ken Cheng, Shelly L. Lorey, Bin Lu, Sabine Wenzel, Audra M. Foshage, Joseph Alvarado, Feng Wang, J. Grace Shaw, Bin Zhao, April M. Weissmiller, Lance R. Thomas, Christopher R. Vakoc, Matthew D. Hall, Scott W. Hiebert, Qi Liu, Shaun R. Stauffer, Stephen W. Fesik & William P. Tansey. (2019) Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity. Cell Reports 26:11, pages 2916-2928.e13.
Crossref
Crossref
Emmanuelle C. Genin, Sylvie Bannwarth, Françoise Lespinasse, Bernardo Ortega-Vila, Konstantina Fragaki, Kie Itoh, Elodie Villa, Sandra Lacas-Gervais, Manu Jokela, Mari Auranen, Emil Ylikallio, Alessandra Mauri-Crouzet, Henna Tyynismaa, Anna Vihola, Gaelle Augé, Charlotte Cochaud, Hiromi Sesaki, Jean-Ehrland Ricci, Bjarne Udd, Cristofol Vives-Bauza & Véronique Paquis-Flucklinger. (2018) Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases. Neurobiology of Disease 119, pages 159-171.
Crossref
Crossref
Ralitsa R. Madsen, Bart Vanhaesebroeck & Robert K. Semple. (2018) Cancer-Associated PIK3CA Mutations in Overgrowth Disorders. Trends in Molecular Medicine 24:10, pages 856-870.
Crossref
Crossref
Susan Keay, Shreeram C. Nallar, Padmaja Gade, Chen-Ou Zhang & Dhan V. Kalvakolanu. (2018) Oncosuppressor protein p53 and cyclin-dependent kinase inhibitor p21 regulate interstitial cystitis associated gene expression. Cytokine 110, pages 110-115.
Crossref
Crossref
George Papaxoinis, Vassiliki Kotoula, Eleni Giannoulatou, Georgia-Angeliki Koliou, Vasilios Karavasilis, Sotirios Lakis, Andreas Koureas, Mattheos Bobos, Elpida Chalaralambous, Emily Daskalaki, Kyriakos Chatzopoulos, George Tsironis, Elisavet Pazarli, Sofia Chrisafi, Epaminontas Samantas, Ioannis G. Kaklamanos, Ioannis Varthalitis, Athina Konstantara, Konstantinos N. Syrigos, George Pentheroudakis, Dimitrios Pectasides & George Fountzilas. (2018) Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Medical Oncology 35:7.
Crossref
Crossref
Maxime Parisotto, Elise Grelet, Rana El Bizri, Yongyuan Dai, Julie Terzic, Doriane Eckert, Laetitia Gargowitsch, Jean-Marc Bornert & Daniel Metzger. (2018) PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo. Journal of Experimental Medicine 215:6, pages 1749-1763.
Crossref
Crossref
Adam Naguib, Grinu Mathew, Colleen R. Reczek, Kaitlin Watrud, Alexandra Ambrico, Tali Herzka, Irene Casanova Salas, Matthew F. Lee, Nour El-Amine, Wu Zheng, M. Emilia Di Francesco, Joseph R. Marszalek, Darryl J. Pappin, Navdeep S. Chandel & Lloyd C. Trotman. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Reports 23:1, pages 58-67.
Crossref
Crossref
Ann E. Zeleniak, Wei Huang, Melissa L. Fishel & Reginald Hill. (2018) PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma. Neoplasia 20:1, pages 12-24.
Crossref
Crossref
M Rupp, J Hagenbuchner, B Rass, H Fiegl, U Kiechl-Kohlendorfer, P Obexer & M J Ausserlechner. (2017) FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3. Oncogene 36:44, pages 6190-6203.
Crossref
Crossref
Abdelhalim Loukil, Kati Tormanen & Christine Sütterlin. (2017) The daughter centriole controls ciliogenesis by regulating Neurl-4 localization at the centrosome. Journal of Cell Biology 216:5, pages 1287-1300.
Crossref
Crossref
Wen Wen Xu, Bin Li, Xin Yuan Guan, Sookja K. Chung, Yang Wang, Yim Ling Yip, Simon Y. K. Law, Kin Tak Chan, Nikki P. Y. Lee, Kwok Wah Chan, Li Yan Xu, En Min Li, Sai Wah Tsao, Qing-Yu He & Annie L. M. Cheung. (2017) Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nature Communications 8:1.
Crossref
Crossref
Crystal A. Tonnessen-Murray, Guillermina Lozano & James G. Jackson. (2017) The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence. Cold Spring Harbor Perspectives in Medicine 7:2, pages a026112.
Crossref
Crossref
R Molinuevo, A Freije, I de Pedro, S W Stoll, J T Elder & A Gandarillas. (2016) FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53. Oncogene 36:7, pages 956-965.
Crossref
Crossref
Si-Jie Li, Xin-Yue Liang, Hai-Jun Li, Wei Li, Lei Zhou, Hua-Qiu Chen, Song-Gen Ye, De-Hai Yu & Jiu-Wei Cui. (2017) Low-dose irradiation promotes proliferation of the human breast cancer MDA-MB-231 cells through accumulation of mutant P53. International Journal of Oncology 50:1, pages 290-296.
Crossref
Crossref
María Antonia Lizarbe, Jorge Calle-Espinosa, Eva Fernández-Lizarbe, Sara Fernández-Lizarbe, Miguel Ángel Robles, Nieves Olmo & Javier Turnay. (2017) Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. BioMed Research International 2017, pages 1-38.
Crossref
Crossref
Teresa Davoli, Kristen E. Mengwasser, Jingjing Duan, Ting Chen, Camilla Christensen, Eric C. Wooten, Anthony N. Anselmo, Mamie Z. Li, Kwok-Kin Wong, Kristopher T. Kahle & Stephen J. Elledge. (2017) Functional genomics reveals that tumors with activating phosphoinositide 3-kinase mutations are dependent on accelerated protein turnover. Genes & Development 30:24, pages 2684-2695.
Crossref
Crossref
Qing-Bai She, Sofia K. Gruvberger-Saal, Matthew Maurer, Yilun Chen, Mervi Jumppanen, Tao Su, Meaghan Dendy, Ying-Ka Ingar Lau, Lorenzo Memeo, Hugo M. Horlings, Marc J. van de Vijver, Jorma Isola, Hanina Hibshoosh, Neal Rosen, Ramon Parsons & Lao H. Saal. (2016) Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer. BMC Cancer 16:1.
Crossref
Crossref
Isabel Huang-Doran, Patsy Tomlinson, Felicity Payne, Alexandra Gast, Alison Sleigh, William Bottomley, Julie Harris, Allan Daly, Nuno Rocha, Simon Rudge, Jonathan Clark, Albert Kwok, Stefano Romeo, Emma McCann, Barbara Müksch, Mehul Dattani, Stefano Zucchini, Michael Wakelam, Lazaros C. Foukas, David B. Savage, Rinki Murphy, Stephen O’Rahilly, Inês Barroso & Robert K. Semple. (2016) Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. JCI Insight 1:17.
Crossref
Crossref
Madhuparna Roy, Kie Itoh, Miho Iijima & Hiromi Sesaki. (2016) Parkin suppresses Drp1-independent mitochondrial division. Biochemical and Biophysical Research Communications 475:3, pages 283-288.
Crossref
Crossref
Michael G. Kemp & Aziz Sancar. (2016) ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. Journal of Biological Chemistry 291:17, pages 9330-9342.
Crossref
Crossref
Felix Y. Feng, Yu Zhang, Vishal Kothari, Joseph R. Evans, William C. Jackson, Wei Chen, Skyler B. Johnson, Connor Luczak, Shaomeng Wang & Daniel A. Hamstra. (2016) MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Neoplasia 18:4, pages 213-222.
Crossref
Crossref
Cristiana Lo Nigro, Vincenzo Ricci, Daniela Vivenza, Cristina Granetto, Teresa Fabozzi, Emanuela Miraglio & Marco C Merlano. (2016) Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy. World Journal of Gastroenterology 22:30, pages 6944.
Crossref
Crossref
Stephen Murata, Catherine Zhang, Nathan Finch, Kevin Zhang, Loredana Campo & Eun-Kyoung Breuer. (2016) Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
Gibok Lee, Taek-In Oh, Ki Bum Um, Hyeshin Yoon, Jaekyoung Son, Byeong Mo Kim, Hong-Il Kim, Hackyoung Kim, Young Jun Kim, Chang-Soo Lee & Ji-Hong Lim. (2016) Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells. Biochemical and Biophysical Research Communications 470:1, pages 181-186.
Crossref
Crossref
Xi Kang, Chang Song, Xiao Du, Cong Zhang, Yu Liu, Ling Liang, Jinxue He, Kristy Lamb, Wen H. Shen & Yuxin Yin. (2015) PTEN stabilizes TOP2A and regulates the DNA decatenation. Scientific Reports 5:1.
Crossref
Crossref
Cristina Pérez-Ramírez, Marisa Cañadas-Garre, Miguel Ángel Molina, María José Faus-Dáder & Miguel Ángel Calleja-Hernández. (2015) PTEN and PI3K/AKT in non-small-cell lung cancer. Pharmacogenomics 16:16, pages 1843-1862.
Crossref
Crossref
Dawid G. Nowak, Hyejin Cho, Tali Herzka, Kaitlin Watrud, Daniel V. DeMarco, Victoria M.Y. Wang, Serif Senturk, Christof Fellmann, David Ding, Tumas Beinortas, David Kleinman, Muhan Chen, Raffaella Sordella, John E. Wilkinson, Mireia Castillo-Martin, Carlos Cordon-Cardo, Brian D. Robinson & Lloyd C. Trotman. (2015)
MYC Drives
Pten/Trp53
-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2
. Cancer Discovery 5:6, pages 636-651.
Crossref
Crossref
Tushar B. Deb, Annie H. Zuo, Robert J. Barndt, Surojeet Sengupta, Radmila Jankovic & Michael D. Johnson. (2015) Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process. Breast Cancer Research and Treatment 150:2, pages 347-361.
Crossref
Crossref
Valenti Gomez, Ramazan Gundogdu, Marta Gomez, Lily Hoa, Neelam Panchal, Mark O'Driscoll & Alexander Hergovich. (2015) Regulation of DNA damage responses and cell cycle progression by hMOB2. Cellular Signalling 27:2, pages 326-339.
Crossref
Crossref
Tulin Ersahin, Nurcan Tuncbag & Rengul Cetin-Atalay. (2015) The PI3K/AKT/mTOR interactive pathway. Molecular BioSystems 11:7, pages 1946-1954.
Crossref
Crossref
Madhuri Kalathur, Diletta Di Mitri & Andrea Alimonti. 2015. Stress Response Pathways in Cancer. Stress Response Pathways in Cancer
157
182
.
Yusuke Kageyama, Masahiko Hoshijima, Kinya Seo, Djahida Bedja, Polina Sysa‐Shah, Shaida A Andrabi, Weiran Chen, Ahmet Höke, Valina L Dawson, Ted M Dawson, Kathleen Gabrielson, David A Kass, Miho Iijima & Hiromi Sesaki. (2014)
Parkin‐independent mitophagy requires
D
rp1 and maintains the integrity of mammalian heart and brain
. The EMBO Journal 33:23, pages 2798-2813.
Crossref
Crossref
Ana Freije, Rut Molinuevo, Laura Ceballos, Marta Cagigas, Pilar Alonso-Lecue, René Rodriguez, Pablo Menendez, Daniel Aberdam, Ernesto De Diego & Alberto Gandarillas. (2014) Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage. Cell Reports 9:4, pages 1349-1360.
Crossref
Crossref
Francesco Sclafani, David Gonzalez, David Cunningham, Sanna Hulkki Wilson, Clare Peckitt, Josep Tabernero, Bengt Glimelius, Andrés Cervantes, Alice Dewdney, Andrew Wotherspoon, Gina Brown, Diana Tait, Jacqueline Oates & Ian Chau. (2014) TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial. JNCI: Journal of the National Cancer Institute 106:7.
Crossref
Crossref
Hyejin Cho, Tali Herzka, Wu Zheng, Jun Qi, John E. Wilkinson, James E. Bradner, Brian D. Robinson, Mireia Castillo-Martin, Carlos Cordon-Cardo & Lloyd C. Trotman. (2014)
RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of
Pten
-Mutant Metastasis
. Cancer Discovery 4:3, pages 318-333.
Crossref
Crossref
Zhuo Sun, Chuanxin Huang, Jinxue He, Kristy L. Lamb, Xi Kang, Tingting Gu, Wen Hong Shen & Yuxin Yin. (2014) PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development. Cell Reports 6:5, pages 844-854.
Crossref
Crossref
Sameh Mikhail & Tanios Bekaii-Saab. (2013)
RAS
mutations: impact on treatment outcome
. Colorectal Cancer 2:6, pages 525-534.
Crossref
Crossref
Jinsong Zhang, Peijing Zhang, Yongkun Wei, Hai-long Piao, Wenqi Wang, Subbareddy Maddika, Min Wang, Dahu Chen, Yutong Sun, Mien-Chie Hung, Junjie Chen & Li Ma. (2013) Deubiquitylation and stabilization of PTEN by USP13. Nature Cell Biology 15:12, pages 1486-1494.
Crossref
Crossref
Veronique Juvin, Mouhannad Malek, Karen E. Anderson, Carine Dion, Tamara Chessa, Charlotte Lecureuil, G. John Ferguson, Sabina Cosulich, Phillip T. Hawkins & Len R. Stephens. (2013) Signaling via Class IA Phosphoinositide 3-Kinases (PI3K) in Human, Breast-Derived Cell Lines. PLoS ONE 8:10, pages e75045.
Crossref
Crossref
Ana Custodio & Jaime Feliu. (2013) Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: Beyond KRAS mutations. Critical Reviews in Oncology/Hematology 85:1, pages 45-81.
Crossref
Crossref
Olivier Bouché & Pierre Laurent-PuigF. Di Fiore & P. Michel. 2013. Médecine personnalisée en cancérologie digestive. Médecine personnalisée en cancérologie digestive
177
191
.
Matthias Christgen, Monika Noskowicz, Charlotte Heil, Elisa Schipper, Henriette Christgen, Robert Geffers, Hans Kreipe & Ulrich Lehmann. (2012) IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes. Laboratory Investigation 92:11, pages 1635-1647.
Crossref
Crossref
Le Luo, Jaspal Kaur Kumar & Marie-Véronique Clément. (2012) Redox control of cytosolic Akt phosphorylation in PTEN null cells. Free Radical Biology and Medicine 53:9, pages 1697-1707.
Crossref
Crossref
Ana M. Mendes-Pereira, Christopher J. Lord & Alan Ashworth. (2012) NLK Is a Novel Therapeutic Target for PTEN Deficient Tumour Cells. PLoS ONE 7:10, pages e47249.
Crossref
Crossref
Efsevia VakianiManickam JanakiramanRonglai ShenRileen SinhaZhaoshi ZengJinru ShiaAndrea CercekNancy KemenyMichael D'AngelicaAgnes VialeAdriana HeguyPhilip PatyTimothy A. ChanLeonard B. SaltzMartin WeiserDavid B. Solit. (2012) Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas. Journal of Clinical Oncology 30:24, pages 2956-2962.
Crossref
Crossref
Hongyun Wang, Youyuan Xu, Zi Fang, Sen Chen, Steven P. Balk & Xin Yuan. (2012) Doxycycline Regulated Induction of AKT in Murine Prostate Drives Proliferation Independently of p27 Cyclin Dependent Kinase Inhibitor Downregulation. PLoS ONE 7:7, pages e41330.
Crossref
Crossref
Y Bian, B Hall, Z-J Sun, A Molinolo, W Chen, J S Gutkind, C V Waes & A B Kulkarni. (2011) Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 31:28, pages 3322-3332.
Crossref
Crossref
Jeffrey J. Wallin, Jane Guan, Kyle A. Edgar, Wei Zhou, Ross Francis, Anthony C. Torres, Peter M. Haverty, Jeffrey Eastham-Anderson, Sabrina Arena, Alberto Bardelli, Sue Griffin, John E. Goodall, Kyla M. Grimshaw, Klaus P. Hoeflich, Christopher Torrance, Marcia Belvin & Lori S. Friedman. (2012) Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes. PLoS ONE 7:5, pages e36402.
Crossref
Crossref
M V Astle, K M Hannan, P Y Ng, R S Lee, A J George, A K Hsu, Y Haupt, R D Hannan & R B Pearson. (2011) AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 31:15, pages 1949-1962.
Crossref
Crossref
Elizabeth M. Davies, David A. Sheffield, Priyanka Tibarewal, Clare G. Fedele, Christina A. Mitchell & Nicholas R. Leslie. 2012. Phosphoinositides I: Enzymes of Synthesis and Degradation. Phosphoinositides I: Enzymes of Synthesis and Degradation
281
336
.
Theodore P. Nicolaides, Huifang Li, David A. Solomon, Sujatmi Hariono, Rintaro Hashizume, Krister Barkovich, Suzanne J. Baker, Barbara S. Paugh, Chris Jones, Tim Forshew, Guy F. Hindley, J. Graeme Hodgson, Jung-Sik Kim, David H. Rowitch, William A. Weiss, Todd A. Waldman & C. David James. (2011)
Targeted Therapy for
BRAFV600E
Malignant Astrocytoma
. Clinical Cancer Research 17:24, pages 7595-7604.
Crossref
Crossref
Quang-Dé Nguyen, Meg Perumal, Todd A. Waldman & Eric O. Aboagye. (2011) Glucose Metabolism Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography Is Independent of PTEN/AKT Status in Human Colon Carcinoma Cells. Translational Oncology 4:4, pages 241-248.
Crossref
Crossref
Ingirídur Skírnisdóttir & Tomas Seidal. (2011) Prognostic Impact of Concomitant p53 and PTEN on Outcome in Early Stage (FIGO I-II) Epithelial Ovarian Cancer. International Journal of Gynecological Cancer 21:6, pages 1024-1031.
Crossref
Crossref
Muhan Chen, Christopher P. Pratt, Martha E. Zeeman, Nikolaus Schultz, Barry S. Taylor, Audrey O'Neill, Mireia Castillo-Martin, Dawid G. Nowak, Adam Naguib, Danielle M. Grace, Jernej Murn, Nick Navin, Gurinder S. Atwal, Chris Sander, William L. Gerald, Carlos Cordon-Cardo, Alexandra C. Newton, Brett S. Carver & Lloyd C. Trotman. (2011) Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression. Cancer Cell 20:2, pages 173-186.
Crossref
Crossref
Hui-Fang Li, Adam Keeton, Michele Vitolo, Clinton Maddox, Lynn Rasmussen, Judith Hobrath, E. Lucille White, Ben Ho Park, Gary A. Piazza, Jung-Sik Kim & Todd Waldman. (2011) A High-Throughput Screen with Isogenic PTEN+/+ and PTEN–/– Cells Identifies CID1340132 as a Novel Compound That Induces Apoptosis in PTEN and PIK3CA Mutant Human Cancer Cells. SLAS Discovery 16:4, pages 383-393.
Crossref
Crossref
Jessica R. Adams, Keli Xu, Jeff C. Liu, Natalia M. Ruiz Agamez, Amanda J. Loch, Ruth G. Wong, Wei Wang, Katherine L. Wright, Timothy F. Lane, Eldad Zacksenhaus & Sean E. Egan. (2011)
Cooperation between
Pik3ca
and p53 Mutations in Mouse Mammary Tumor Formation
. Cancer Research 71:7, pages 2706-2717.
Crossref
Crossref
Chun-Ju Chang, Chi-Hong Chao, Weiya Xia, Jer-Yen Yang, Yan Xiong, Chia-Wei Li, Wen-Hsuan Yu, Sumaiyah K. Rehman, Jennifer L. Hsu, Heng-Huan Lee, Mo Liu, Chun-Te Chen, Dihua Yu & Mien-Chie Hung. (2011) p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology 13:3, pages 317-323.
Crossref
Crossref
Tijana Andjelkovic, Jasna Bankovic, Jelena Stojsic, Vedrana Milinkovic, Ana Podolski-Renic, Sabera Ruzdijic & Nikola Tanic. (2011) Coalterations of p53 and PTEN tumor suppressor genes in non–small cell lung carcinoma patients. Translational Research 157:1, pages 19-28.
Crossref
Crossref
F Di Fiore, R Sesboüé, P Michel, J C Sabourin & T Frebourg. (2010) Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer. British Journal of Cancer 103:12, pages 1765-1772.
Crossref
Crossref
Jean-Marc Zingg, Roksan Libinaki, Chao-Qiang Lai, Mohsen Meydani, Robert Gianello, Esra Ogru & Angelo Azzi. (2010) Modulation of gene expression by α-tocopherol and α-tocopheryl phosphate in THP-1 monocytes. Free Radical Biology and Medicine 49:12, pages 1989-2000.
Crossref
Crossref
Siyuan Zhang & Dihua Yu. (2010) PI(3)King Apart PTEN's Role in Cancer. Clinical Cancer Research 16:17, pages 4325-4330.
Crossref
Crossref
Hyun-Ja Nam, Sunyoung Chae, Seung-Hoon Jang, Hyeseong Cho & Jae-Ho Lee. (2010) The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability. Carcinogenesis 31:9, pages 1531-1540.
Crossref
Crossref
Sherene LoiBenjamin Haibe-Kains, Samira MajjajFrancoise LallemandVirginie DurbecqDenis LarsimontAna M. Gonzalez-Angulo, Lajos Pusztai, W. Fraser SymmansAlberto BardelliPaul EllisAndrew N. J. TuttCheryl E. GillettBryan T. Hennessy, Gordon B. Mills, Wayne A. Phillips, Martine J. PiccartTerence P. Speed, Grant A. McArthurChristos Sotiriou. (2010)
PIK3CA
mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer
. Proceedings of the National Academy of Sciences 107:22, pages 10208-10213.
Crossref
Crossref
Andrea Alimonti, Caterina Nardella, Zhenbang Chen, John G. Clohessy, Arkaitz Carracedo, Lloyd C. Trotman, Ke Cheng, Shohreh Varmeh, Sara C. Kozma, George Thomas, Erika Rosivatz, Rudiger Woscholski, Francesco Cognetti, Howard I. Scher & Pier Paolo Pandolfi. (2010) A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. Journal of Clinical Investigation 120:3, pages 681-693.
Crossref
Crossref
Marco A. Pierotti, Tiziana Negri, Elena Tamborini, Federica Perrone, Sabrina Pricl & Silvana Pilotti. (2010) Targeted Therapies: The Rare Cancer Paradigm. Molecular Oncology 4:1, pages 19-37.
Crossref
Crossref
Yardena Samuels & Todd Waldman. 2011. Phosphoinositide 3-kinase in Health and Disease. Phosphoinositide 3-kinase in Health and Disease
21
41
.
Y Aylon, N Yabuta, H Besserglick, Y Buganim, V Rotter, H Nojima & M Oren. (2009) Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene 28:50, pages 4469-4479.
Crossref
Crossref
Ana M. Mendes‐Pereira, Sarah A. Martin, Rachel Brough, Afshan McCarthy, Jessica R. Taylor, Jung‐Sik Kim, Todd Waldman, Christopher J. Lord & Alan Ashworth. (2009)
Synthetic lethal targeting of
PTEN
mutant cells with PARP inhibitors
. EMBO Molecular Medicine 1:6-7, pages 315-322.
Crossref
Crossref
Zhenbang ChenArkaitz CarracedoHui-Kuan LinJason A. KoutcherNille BehrendtAinara EgiaAndrea AlimontiBrett S. CarverWilliam GeraldJulie Teruya-FeldsteinMassimo LodaPier Paolo Pandolfi. (2009)
Differential p53-Independent Outcomes of p19
Arf
Loss in Oncogenesis
. Science Signaling 2:84.
Crossref
Crossref
Jongchan Kim, Isam-Eldin A. Eltoum, Meejeon Roh, Jie Wang & Sarki A. Abdulkadir. (2009) Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer. PLoS Genetics 5:7, pages e1000542.
Crossref
Crossref
A Oden-Gangloff, F Di Fiore, F Bibeau, A Lamy, G Bougeard, F Charbonnier, F Blanchard, D Tougeron, M Ychou, F Boissière, F Le Pessot, J-C Sabourin, J-J Tuech, P Michel & T Frebourg. (2009) TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy. British Journal of Cancer 100:8, pages 1330-1335.
Crossref
Crossref
Lluis Catasus, Alberto Gallardo, Miriam Cuatrecasas & Jaime Prat. (2009) Concomitant PI3K–AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis. Modern Pathology 22:4, pages 522-529.
Crossref
Crossref
Yoo-Kyung Lee & Noh-Hyun Park. (2009) Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers. Gynecologic Oncology 112:3, pages 475-480.
Crossref
Crossref
A. Oden Gangloff, F. Di Fiore, F. Bibeau, A. Lamy, G. Bougeard, F. Charbonnier, F. Blanchard, D. Tougeron, M. Ychou, F. Boissière, F. Le Pessot, J.C. Sabourin, J.J. Tuech, P. Michel & T. Frébourg. (2009) CO.21 Intérêt de la recherche des mutations de TP53 chez les patients sans mutation de KRAS traités par cetuximab plus chimiothérapie pour un cancer colorectal métastatique. Gastroentérologie Clinique et Biologique 33:3, pages A11.
Crossref
Crossref
Marta Moral, Carmen Segrelles, M. Fernanda Lara, Ana Belén Martínez-Cruz, Corina Lorz, Mirentxu Santos, Ramón García-Escudero, Jerry Lu, Kaoru Kiguchi, Agueda Buitrago, Clotilde Costa, Cristina Saiz, Jose L. Rodriguez-Peralto, Francisco J. Martinez-Tello, Maria Rodriguez-Pinilla, Montserrat Sanchez-Cespedes, Marina Garín, Teresa Grande, Ana Bravo, John DiGiovanni & Jesús M. Paramio. (2009)
Akt Activation Synergizes with
Trp53
Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell Carcinoma
. Cancer Research 69:3, pages 1099-1108.
Crossref
Crossref
Nader ChalhoubSuzanne J. Baker. (2009) PTEN and the PI3-Kinase Pathway in Cancer. Annual Review of Pathology: Mechanisms of Disease 4:1, pages 127-150.
Crossref
Crossref
Oliver Renner, Carmen Blanco-Aparicio, Maja Grassow, Marta Cañamero, Juan F.M. Leal & Amancio Carnero. (2008) Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation. Cancer Research 68:23, pages 9643-9653.
Crossref
Crossref
Nadia Danilova, Kathleen M. Sakamoto & Shuo Lin. (2008) p53 family in development. Mechanisms of Development 125:11-12, pages 919-931.
Crossref
Crossref
J.-S. Kim, C. Bonifant, F. Bunz, W. S. Lane & T. Waldman. (2008) Epitope tagging of endogenous genes in diverse human cell lines. Nucleic Acids Research 36:19, pages e127-e127.
Crossref
Crossref
T L Yuan & L C Cantley. (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27:41, pages 5497-5510.
Crossref
Crossref
Ran Zhang, Naren L. Banik & Swapan K. Ray. (2007) Combination of all-trans retinoic acid and interferon-gamma upregulated p27kip1 and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer Chemotherapy and Pharmacology 62:3, pages 407-416.
Crossref
Crossref
Carlos A. Scrideli, Carlos G. CarlottiJr.Jr., Oswaldo K. Okamoto, Vanessa S. Andrade, Maria A. A. Cortez, Fábio J. N. Motta, Agda K. Lucio-Eterovic, Luciano Neder, Sérgio Rosemberg, Sueli M. Oba-Shinjo, Suely K. N. Marie & Luíz G. Tone. (2008) Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. Journal of Neuro-Oncology 88:3, pages 281-291.
Crossref
Crossref
Shashwati Basak, Suzanne B.R. Jacobs, Adam J. Krieg, Navneeta Pathak, Qi Zeng, Philipp Kaldis, Amato J. Giaccia & Laura D. Attardi. (2008) The Metastasis-Associated Gene Prl-3 Is a p53 Target Involved in Cell-Cycle Regulation. Molecular Cell 30:3, pages 303-314.
Crossref
Crossref
Yan-Ying Huo, Gang Li, Rui-Feng Duan, Qiao Gou, Chun-Ling Fu, Ying-Chun Hu, Bo-Qiang Song, Zhi-Hua Yang, De-Chang Wu & Ping-Kun Zhou. (2008) PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radical Biology and Medicine 44:8, pages 1578-1591.
Crossref
Crossref
H. Kuwana, Y. Terada, T. Kobayashi, T. Okado, J.M. Penninger, J. Irie-Sasaki, T. Sasaki & S. Sasaki. (2008) The phosphoinositide-3 kinase γ–Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity. Kidney International 73:4, pages 430-445.
Crossref
Crossref
Ruth H. Paulssen, Bjørn Moe, Halvor Grønaas & Anne Ørbo. (2008) Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids 73:1, pages 116-128.
Crossref
Crossref
Arnaud Parcellier, Lionel A. Tintignac, Elena Zhuravleva & Brian A. Hemmings. (2008) PKB and the mitochondria: AKTing on apoptosis. Cellular Signalling 20:1, pages 21-30.
Crossref
Crossref
Chung-Han Lee, Ken Inoki, Magdalena Karbowniczek, Emmanuel Petroulakis, Nahum Sonenberg, Elizabeth Petri Henske & Kun-Liang Guan. (2007) Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. The EMBO Journal 26:23, pages 4812-4823.
Crossref
Crossref
Carlo Rago, Bert Vogelstein & Fred Bunz. (2007) Genetic knockouts and knockins in human somatic cells. Nature Protocols 2:11, pages 2734-2746.
Crossref
Crossref
Challice L. Bonifant, Jung-Sik Kim & Todd Waldman. (2007) NHERFs, NEP, MAGUKs, and more: Interactions that regulate PTEN. Journal of Cellular Biochemistry 102:4, pages 878-885.
Crossref
Crossref